NeuralCipher Open access
Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease.
DOI: 10.3390/ph14080775PMID: 34451872
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
21.482 articles found
Source record
Identification of pimavanserin tartrate as a potent Ca<sup>2+</sup>-calcineurin-NFAT pathway inhibitor for glioblastoma therapy.
DOI: 10.1038/s41401-021-00724-2PMID: 34363007
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Does antiretroviral therapy alter the course of Parkinson's disease in people living with HIV?
DOI: 10.1007/s13365-021-00999-5PMID: 34351573
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?
DOI: 10.3390/cells10081992PMID: 34440761
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Eight-year follow-up outcome of subthalamic deep brain stimulation for Parkinson's disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity.
DOI: 10.1111/cns.13713PMID: 34350691
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Association of COMT rs4680 and MAO-B rs1799836 polymorphisms with levodopa-induced dyskinesia in Parkinson's disease-a meta-analysis.
DOI: 10.1007/s10072-021-05509-3PMID: 34346015
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders.
DOI: 10.1155/2021/9971885PMID: 34394839
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
The Therapeutic Potential of Celastrol in Central Nervous System Disorders: Highlights from In Vitro and In Vivo Approaches.
DOI: 10.3390/molecules26154700PMID: 34361850
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Effects of rehabilitation on reducing dyskinesias in a Parkinson's disease patient abusing therapy with levodopa-carbidopa intestinal gel: a paradigmatic case report and literature review.
DOI: 10.23812/21-229-lPMID: 34337930
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies.
DOI: 10.1016/j.bioorg.2021.105233PMID: 34390968
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Dysarthria treatment for Parkinson's disease: one-year follow-up of SPEAK OUT!<sup>®</sup> with the LOUD Crowd<sup>®</sup>.
DOI: 10.1080/14015439.2021.1958001PMID: 34338571
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
MPTP-induced mouse model of Parkinson's disease: A promising direction of therapeutic strategies.
DOI: 10.17305/bjbms.2020.5181PMID: 33357211
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.